Literature DB >> 10663962

Recombinant tissue-plasminogen activator-induced thrombolysis after cerebral thromboembolism in mice.

E Kilic1, D M Hermann, K A Hossmann.   

Abstract

The effects of intracarotid thrombolysis with recombinant tissue-plasminogen activator (rt-PA) on cerebral laser Doppler flow (LDF) and the degree of ischemic injury, as revealed by triphenyltetrazolium chloride (TTC) staining, were studied 24 h following cerebral thromboembolism in mice. Thromboembolization with fibrin-rich clot material (0.28-microl clot volume) led to an LDF decline to about 20-30% of baseline in untreated mice, which resulted in reproducible infarcts of the middle cerebral artery (MCA) territory (122.8 +/- 29.4 mm(3)). Administration of rt-PA (10 mg/kg) 15 min after clot injection induced a progressive LDF restoration to approximately 115% of control values after 2 h, and brought about a significant reduction of the infarct volume (62.3 +/- 42.4 mm(3)). Our results indicate that ischemic injury may be significantly attenuated by intracarotid thrombolysis. However, injury is not completely reversed, even if reperfusion is initiated as early as 15 min after embolization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663962     DOI: 10.1007/pl00007430

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier.

Authors:  Dirk M Hermann
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 2.  α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.

Authors:  Guy L Reed; Aiilyan K Houng; Satish Singh; Dong Wang
Journal:  Semin Thromb Hemost       Date:  2016-07-29       Impact factor: 4.180

3.  The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.

Authors:  Yacine Boulaftali; Lamia Lamrani; Marie-Catherine Rouzaud; Stéphane Loyau; Martine Jandrot-Perrus; Marie-Christine Bouton; Benoît Ho-Tin-Noé
Journal:  Thromb Haemost       Date:  2012-03-08       Impact factor: 5.249

Review 4.  Pathophysiology and therapy of experimental stroke.

Authors:  Konstantin-Alexander Hossmann
Journal:  Cell Mol Neurobiol       Date:  2006-05-19       Impact factor: 5.046

5.  ADAMTS13 exerts a thrombolytic effect in microcirculation.

Authors:  Marilena Crescente; Grace M Thomas; Melanie Demers; Jaymie R Voorhees; Siu Ling Wong; Benoit Ho-Tin-Noé; Denisa D Wagner
Journal:  Thromb Haemost       Date:  2012-07-10       Impact factor: 5.249

6.  Thrombotic distal middle cerebral artery occlusion produced by topical FeCl(3) application: a novel model suitable for intravital microscopy and thrombolysis studies.

Authors:  Hulya Karatas; Sefik Evren Erdener; Yasemin Gursoy-Ozdemir; Gunfer Gurer; Figen Soylemezoglu; Andrew K Dunn; Turgay Dalkara
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-16       Impact factor: 6.200

7.  Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.

Authors:  Aiilyan K Houng; Dong Wang; Guy L Reed
Journal:  Exp Neurol       Date:  2014-02-18       Impact factor: 5.330

8.  Animal models of ischemic stroke. Part two: modeling cerebral ischemia.

Authors:  Marco Bacigaluppi; Giancarlo Comi; Dirk M Hermann
Journal:  Open Neurol J       Date:  2010-06-15

Review 9.  Extracellular DNA-A Danger Signal Triggering Immunothrombosis.

Authors:  Chongxu Shi; Luying Yang; Attila Braun; Hans-Joachim Anders
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.